Prolong Pharmaceuticals
Prolong Pharmaceuticals, based in South Plainfield, NJ, is a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for central nervous system, hematology, and respiratory disorders. With a focus on addressing complex diseases like ischemia, hypoxia, stroke, sickle cell disease, and cystic fibrosis, the company leverages its proprietary PEGylation technology to enhance drug delivery and efficacy.
The lead product, PP-007 Sanguinate, is designed to restore physiological balance by delivering oxygen to hypoxic tissues and improving perfusion while reducing inflammation. Prolong Pharmaceuticals aims to meet critical unmet medical needs and revolutionize treatment options for severe and life-threatening conditions through its cutting-edge research and development initiatives.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.